Kun Xiong

Kun Xiong

Regeneron Pharmaceuticals Inc - Warsaw / United States
Natural Sciences / Biological Science
AD Scientific Index ID: 4632671
-
person_outline Kun Xiong's MOST POPULAR ARTICLES
1-) Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agentL Wang, Z Yang, J Fu, H Yin, K Xiong, Q Tan, H Jin, J Li, T Wang, W Tang, ...Free Radical Biology and Medicine 52 (5), 898-908, 20121352012
2-) Inhibition of thioredoxin reductase by a novel series of bis-1, 2-benzisoselenazol-3 (2H)-ones: Organoselenium compounds for cancer therapyJ He, D Li, K Xiong, Y Ge, H Jin, G Zhang, M Hong, Y Tian, J Yin, H ZengBioorganic & medicinal chemistry 20 (12), 3816-3827, 2012762012
3-) Selenium-containing thioredoxin reductase inhibitor ethaselen sensitizes non-small cell lung cancer to radiotherapyL Wang, J Fu, J Wang, C Jin, X Ren, Q Tan, J Li, H Yin, K Xiong, T Wang, ...Anti-Cancer Drugs 22 (8), 732-740, 2011382011
4-) The EN-TEx resource of multi-tissue personal epigenomes & variant-impact modelsJ Rozowsky, J Gao, B Borsari, YT Yang, T Galeev, G Gursoy, CB Epstein, ...Cell 186 (7), 1493-1511, 2023342023
5-) Thioredxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M …J Fu, J Li, Q Tan, H Yin, K Xiong, T Wang, X Ren, H ZengInvestigational new drugs 29, 627-636, 2011302011